Ketorolac for sickle cell vaso-occlusive crisis pain in the emergency department: lack of a narcotic-sparing effect
- 31 August 1992
- journal article
- clinical trial
- Published by Elsevier in Annals of Emergency Medicine
- Vol. 21 (8), 925-928
- https://doi.org/10.1016/s0196-0644(05)82929-4
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- KETOROLAC SUPERIOR TO SUFENTANIL, GIVING LONGER PAIN RELIEF WITH LESS NAUSEA AND LESS RECOVERY TIME AFTER LAPAROSCOPYAnesthesiology, 1991
- EFFECT OF INTRAOPERATIVE KETOROLAC ON RECOVERY AFTER OUTPATIENT LAPAROSCOPYAnesthesiology, 1991
- Intermittent Injection vs Patient-Controlled Analgesia for Sickle Cell Crisis PainArchives of Internal Medicine, 1991
- Pain Management in Sickle Cell DiseaseAnnals of the New York Academy of Sciences, 1989
- The presentation, management and prophylaxis of sickle cell diseaseBlood Reviews, 1989
- The use of patient-controlled analgesia in adolescents with sickle cell pain crisis: A preliminary reportJournal of Pain and Symptom Management, 1988
- The morphine sparing effect of ketorolac tromethamineAnaesthesia, 1987
- Comparison of Intramuscular Ketorolac Tromethamine and Morphine Sulfate for Analgesia of Pain After Major SurgeryPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 1986
- Oral analgesia for treatment of painful crisis in sickle cell anemiaAnnals of Emergency Medicine, 1986
- Management protocol for sickle-cell disease patients with acute pain: Impact on emergency department and narcotic useThe American Journal of Emergency Medicine, 1986